Please confirm you are human

This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.

A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.

Hold with a pointer, or hold Space or Enter.

News

Oncodaily - Oncology News
oncodaily.com > voices > korina-pateli-bell-585428

Korina Pateli - Bell: Bringing Greece’s Lung Cancer Support and Nursing Programs to WCLC 2026 - OncoDaily

5+ min ago   (366+ words) Korina Pateli – Bell, Founder and President at FairLife Lung Cancer Care, shared on LinkedIn: “Looking forward to sharing our work at WCLC2026 in Seoul on Monday. On September 14, I’ll be representing FairLife Lung Cancer Care at WCLC 2026 with two poster presentations,…...

Oncodaily - Oncology News
oncodaily.com > voices > catharine-grimes-wclc-2026-585434

Catharine Grimes: WCLC 2026 Focuses on Making Earlier Detection More Accessible - OncoDaily

29+ min ago   (105+ words) Catharine Grimes: WCLC 2026 Focuses on Making Earlier Detection More Accessible Oncodaily Catharine Grimes: WCLC 2026 Focuses on Making Earlier Detection More Accessible Catharine Grimes, President of the Bristol Myers Squibb Foundation, shared on LinkedIn: “The World Conference on Lung Cancer begins…...

Oncodaily - Oncology News
oncodaily.com > voices > sumanta-k-pal-585407

Sumanta K. Pal: Exploring Multicenter Research Opportunities at City of Hope Arizona - OncoDaily

46+ min ago   (128+ words) OncoDaily is a specialized news and information platform that provides daily updates on oncology research, treatments, clinical trials, and advancements in cancer care. It serves healthcare professionals, researchers, and patients by delivering timely and accurate insights into the latest developments…...

Seeking Alpha
seekingalpha.com > news > 4642302-summit-s-ivonescimab-cuts-death-risk-by-27-percent-versus-keytruda-in-lung-cancer-trial

Summit’s ivonescimab cuts death risk by 27% versus Keytruda in lung cancer trial (SMMT:NASDAQ)

24+ min ago   (64+ words) Seeking Alpha nopparit/iStock via Getty Images Summit Therapeutics (SMMT) on Sunday said ivonescimab significantly extended survival compared with Merck’s (MRK) Keytruda in a late-stage lung cancer trial conducted by its partner Akeso (AKESF) in China. Ivonescimab reduced the risk…...

Medical Dialogues
medicaldialogues.in > oncology > news > salivary-nitrite-shifts-reveal-tumor-specific-cancer-patterns-suggests-systematic-review-179149

Salivary Nitrite Shifts Reveal Tumor-Specific Cancer Patterns, Suggests Systematic Review

3+ hour, 2+ min ago   (183+ words) A recent systematic review published in the Indian Journal of Otolaryngology and Head & Neck Surgery in September 2026 reveals that salivary nitrite concentrations display striking, tumor-specific shifts in cancer patients. While nitrite levels surge in oral squamous cell carcinoma, they decline…...

Oncodaily - Oncology News
oncodaily.com > science > myeloma-paper-of-the-day-585368

Myeloma Paper of the Day, September 13th, Suggested by Robert Orlowski - OncoDaily

1+ hour, 19+ min ago   (253+ words) Myeloma Paper of the Day, September 13th, Suggested by Robert Orlowski / Anastasia Zekeridou, Andre de Menezes Silva Corraes, Blood Cancer Journal, cancer,, Anastasia Zekeridou, Andre de Menezes Silva Corraes, Blood Cancer Journal, cancer, Christoph Schaefers, Darin Carabenciov, Erin Wiedmeier-Nutor, Joselle Cook,…...

Oncodaily - Oncology News
oncodaily.com > voices > julie-mccrossin-585359

Julie McCrossin: The Future of Proton Therapy in Australia - OncoDaily

1+ hour, 31+ min ago   (135+ words) “Proton Therapy is in the news in Australia due to two unsuccessful attempts to introduce this form of radiotherapy into Australia. Here is the latest ABC News story on this issue referring to a series on ABC Radio National’s Background…...

Oncodaily - Oncology News
oncodaily.com > voices > stephanie-haddad-585402

Stephanie Haddad: Honored to Be Included in the Ethical Leadership Spotlight at Holy Cross - OncoDaily

53+ min ago   (128+ words) Stephanie Haddad, Hematology/Oncology Fellow Physician and Wellness Chief Fellow at Mays Cancer Center at UT Health San Antonio, shared on X: “Honored to be included in the Ethical Leadership Spotlight at my alma mater, College of the Holy Cross! My…...

@PRNewswire
prnewswire.com > news-releases > phase-iii-maverick-trial-supports-brain-mri-surveillance-alone-as-standard-of-care-for-small-cell-lung-cancer-302876943.html

Phase III MAVERICK Trial Supports Brain MRI Surveillance Alone as Standard of Care for Small-Cell Lung Cancer

4+ hour, 53+ min ago   (171+ words) Sep 13, 2026, 08:54 ET For decades, PCI has been used after initial therapy for SCLC because studies conducted before routine MRI demonstrated that it reduced brain metastases and improved overall survival. MAVERICK was designed to determine whether modern MRI surveillance could allow…...

Google News
oncodaily.com > voices > miguel-bronchud-585396

Miguel Bronchud: A New Molecular Switch in Prostate Cancer Treatment Resistance

49+ min ago   (480+ words) “Prostate cancers – ‘maybe lost in translation’? New hopes for more effective treatments ‘This is the first time anyone’s ever shown that the identity of the cell can be regulated by inhibiting translation’ said at the Fred Hutch Institute in Seattle…...